Drug Discovery Services Market Size, Share and Forecast 2026
The Drug Discovery Services Market was worth XX billion in 2018 and is forecasted to reach XX billion by 2026, at a CAGR of XX% during the forecast period.
(EMAILWIRE.COM, September 11, 2019 ) Market Overview:
Drug discovery services is an efficient way of the guide, deliver a drug discovery platform in the field of biotechnology and pharmacology. Drug discovery outsourcing is a complex, lengthy, expensive process and the duration for drug discovery is very high.
The Drug Discovery Services Market was worth XX billion in 2018 and is forecasted to reach XX billion by 2026, at a CAGR of XX% during the forecast period.
Market Dynamics:
Increase in outsourcing of research & development and clinical trials of significant drugs by major pharmaceutical companies and availability of advanced diagnostic procedures at service providers for discovery and development of new drugs and also increase in prevalence of infectious diseases and deadly disease such as Ebola, avian flu, seasonal influenza, etc. are driving the drug discovery services market and expected to remain high during the forecast period. Major factors hindering the Drug Discovery Services Market are high cost involved in the research and development of new drugs due to advanced technologies involved in clinical trials and stringent government norms in the usage of animals.
Market Segmentation:
By Process type
• Profiling & lead optimization
• Screening
• Assay development
• Cell engineering
By Service type
• Computational Chemistry
• Medical chemistry
• ADME &DMPK
• Bio chemistry
By Application
• Oncology
• Neurology
• Metabolic & Inflammatory Disease
• Immuno-Oncology
Geographical Analysis:
The Drug Discovery Services Market is segmented into:
• North America
• Europe
• Asia Pacific
• South America
• The Middle East and Africa
Competitive Analysis:
Key Players:
• Piramal Pharma Solutions
• Biopta
• Charles River Laboratories International
• Domainex
• Evotec AG
• Others
View full report: https://www.datamintelligence.com/research-report/drug-discovery-services-market
Download free sample: https://www.datamintelligence.com/download-sample/adaptive-robotics-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Drug discovery services is an efficient way of the guide, deliver a drug discovery platform in the field of biotechnology and pharmacology. Drug discovery outsourcing is a complex, lengthy, expensive process and the duration for drug discovery is very high.
The Drug Discovery Services Market was worth XX billion in 2018 and is forecasted to reach XX billion by 2026, at a CAGR of XX% during the forecast period.
Market Dynamics:
Increase in outsourcing of research & development and clinical trials of significant drugs by major pharmaceutical companies and availability of advanced diagnostic procedures at service providers for discovery and development of new drugs and also increase in prevalence of infectious diseases and deadly disease such as Ebola, avian flu, seasonal influenza, etc. are driving the drug discovery services market and expected to remain high during the forecast period. Major factors hindering the Drug Discovery Services Market are high cost involved in the research and development of new drugs due to advanced technologies involved in clinical trials and stringent government norms in the usage of animals.
Market Segmentation:
By Process type
• Profiling & lead optimization
• Screening
• Assay development
• Cell engineering
By Service type
• Computational Chemistry
• Medical chemistry
• ADME &DMPK
• Bio chemistry
By Application
• Oncology
• Neurology
• Metabolic & Inflammatory Disease
• Immuno-Oncology
Geographical Analysis:
The Drug Discovery Services Market is segmented into:
• North America
• Europe
• Asia Pacific
• South America
• The Middle East and Africa
Competitive Analysis:
Key Players:
• Piramal Pharma Solutions
• Biopta
• Charles River Laboratories International
• Domainex
• Evotec AG
• Others
View full report: https://www.datamintelligence.com/research-report/drug-discovery-services-market
Download free sample: https://www.datamintelligence.com/download-sample/adaptive-robotics-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results